Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
07:45am, Wednesday, 23'rd Nov 2022
Gilead Sciences' first-in-class cancer drug and GILD stock are finally hitting their stride. The oncology business is growing bullishly.
Gilead Sciences: Best Near-Term Biopharma Cap Gain Bet Say Market-Makers
02:30am, Wednesday, 23'rd Nov 2022
Pharmaceuticals producer and developer competitor activities often are hard to separate and the rapid development in biosciences tend to encourage the labeling of stocks as “healthcare”. The Covid
Is it too late to invest in the Biotech stocks?
05:20pm, Tuesday, 22'nd Nov 2022
“IBB” – the iShares Biotechnology ETF has already recovered about 30% over the past five months but Jefferies' Michael Yee is convinced it still has more room to the upside. Yee's bull case for
Buy this Medical Sector Pioneer Stock
01:33pm, Tuesday, 22'nd Nov 2022
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
GILD vs. HALO: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 22'nd Nov 2022
GILD vs. HALO: Which Stock Is the Better Value Option?
U.S. aid shipment of remdesivir arrives in India overnight
09:19am, Saturday, 19'th Nov 2022
The United States sent India 125,000 vials of the anti-viral drug remdesivir Sunday night. Its the fourth assistance flight from the United States to India as a way to help combat the surge in cases.
Dr. Fauci's positive comments on using Gilead's Remdesivir to treat coronavirus
07:18am, Saturday, 19'th Nov 2022
CNBC's Meg Tirrell breaks down White House health advisor Dr. Anthony Fauci's comments on Gilead's possible coronavirus treatment.
Dr. Fauci: Data from remdesivir coronavirus drug trial shows 'quite good news'
07:14am, Saturday, 19'th Nov 2022
White House health advisor Dr. Anthony Fauci's talks about Gilead's possible coronavirus treatment at the White House.
Gilead (GILD) Outperforms YTD: Will It Retain the Momentum?
03:11pm, Friday, 18'th Nov 2022
Biotech giant Gilead (GILD) outperforms the industry and the S&P 500 Index as its core business maintains momentum despite volatility.
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year?
11:17am, Thursday, 17'th Nov 2022
Here is how Gilead Sciences (GILD) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
Gilead Sciences to Present at Upcoming Investor Conferences
04:05pm, Tuesday, 15'th Nov 2022
FOSTER CITY, Calif.--( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
2 Top Biotech Stocks to Buy in November
10:15am, Saturday, 12'th Nov 2022
Both of these companies have potential catalysts on the way.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:32am, Friday, 11'th Nov 2022
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Has This Hot Stock Run Out of Steam?
09:30am, Thursday, 10'th Nov 2022
Shares of Gilead Sciences have been have been on a tear recently.
Why Shares of Gilead Sciences Rose 27.20% in October
11:00am, Tuesday, 08'th Nov 2022
The company's growing oncology portfolio is driving increased revenues.
